Lee Fairlie

13.0k total citations · 2 hit papers
81 papers, 2.0k citations indexed

About

Lee Fairlie is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Lee Fairlie has authored 81 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Infectious Diseases, 22 papers in Epidemiology and 19 papers in Virology. Recurrent topics in Lee Fairlie's work include HIV/AIDS Research and Interventions (44 papers), HIV/AIDS drug development and treatment (24 papers) and HIV Research and Treatment (19 papers). Lee Fairlie is often cited by papers focused on HIV/AIDS Research and Interventions (44 papers), HIV/AIDS drug development and treatment (24 papers) and HIV Research and Treatment (19 papers). Lee Fairlie collaborates with scholars based in South Africa, United States and United Kingdom. Lee Fairlie's co-authors include Allison L. Agwu, Matthew Chersich, Nomathemba Chandiwana, François Venter, Celicia Serenata, Harry Moultrie, Masebole Masenya, Elaine J. Abrams, Andrew Hill and Michelle Moorhouse and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lee Fairlie

78 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

2019 442 citations François Venter, Michelle Moorhouse et al. New England Journal of Medicine profile →
COVID-19 in Africa: care and protection for frontline healthcare workers

2020 283 citations Matthew Chersich, Lee Fairlie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lee Fairlie South Africa	21	1.4k	465	458	456	344	81	2.0k
Kennedy Otwombe South Africa	21	988 0.7×	208 0.4×	601 1.3×	363 0.8×	414 1.2×	138	1.7k
Guerino Chalamilla Tanzania	24	1.2k 0.9×	366 0.8×	607 1.3×	287 0.6×	510 1.5×	47	1.9k
Allison Zerbe United States	25	1.4k 1.0×	232 0.5×	756 1.7×	292 0.6×	874 2.5×	76	1.9k
Stephanie Shiau United States	22	845 0.6×	535 1.2×	329 0.7×	434 1.0×	190 0.6×	99	1.6k
Kenneth L. Dominguez United States	18	852 0.6×	224 0.5×	692 1.5×	258 0.6×	312 0.9×	38	1.7k
Victor Musiime Uganda	23	1.1k 0.8×	302 0.6×	332 0.7×	495 1.1×	347 1.0×	121	1.6k
Sharon Weissman United States	26	1.6k 1.2×	734 1.6×	1.1k 2.5×	384 0.8×	425 1.2×	126	2.5k
Tamsin K. Phillips South Africa	25	1.3k 1.0×	263 0.6×	631 1.4×	214 0.5×	891 2.6×	80	1.8k
Jamie I. Forrest Canada	20	1.1k 0.8×	223 0.5×	588 1.3×	294 0.6×	463 1.3×	50	1.8k
Allison L. Agwu United States	25	1.7k 1.2×	326 0.7×	972 2.1×	465 1.0×	657 1.9×	115	2.3k

Countries citing papers authored by Lee Fairlie

Since Specialization

Citations

This map shows the geographic impact of Lee Fairlie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Fairlie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Fairlie more than expected).

Fields of papers citing papers by Lee Fairlie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Fairlie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Fairlie. The network helps show where Lee Fairlie may publish in the future.

Co-authorship network of co-authors of Lee Fairlie

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Fairlie. A scholar is included among the top collaborators of Lee Fairlie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Fairlie. Lee Fairlie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seddon, James A., Neil Martinson, Lee Fairlie, et al.. (2025). Acceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatment. PubMed. 2(3). 129–136. 1 indexed citations

Dagnew, Alemnew F., Ling Han, Kogieleum Naidoo, et al.. (2025). Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E–4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial. The Lancet HIV. 12(8). e546–e555. 2 indexed citations

Fairlie, Lee, et al.. (2025). Characterizing the HIV care continuum among children and adolescents with HIV in eastern and southern Africa in the era of “Universal Test and Treat”: A systematic review and meta‐analysis. Journal of the International AIDS Society. 28(6). e26526–e26526.

Cutland, Clare, Mercedes Bonet, Ángela Gentile, et al.. (2024). Burden of Lassa fever disease in pregnant women and children and options for prevention. Vaccine. 43(Pt 1). 126479–126479. 3 indexed citations

Cutland, Clare, Shobna Sawry, Lee Fairlie, et al.. (2024). Obstetric and neonatal outcomes in South Africa. Vaccine. 42(6). 1352–1362. 1 indexed citations

Zehrung, Darin, Bruce L. Innis, Auliya A. Suwantika, et al.. (2024). Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations. Vaccines. 12(11). 1258–1258. 1 indexed citations

Stoner, Marie C. D., Florence Mathebula, Prisca Mutero, et al.. (2024). Acceptability of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) during Pregnancy in Malawi, South Africa, Uganda, and Zimbabwe. AIDS and Behavior. 28(11). 3615–3628. 3 indexed citations

Montgomery, Elizabeth, Lee Fairlie, Florence Mathebula, et al.. (2023). Acceptability of the Dapivirine Vaginal Ring and Oral Truvada Among African Users in Late-Stage of Pregnancy. AIDS and Behavior. 28(3). 963–973. 5 indexed citations

Fairlie, Lee, Emma Kalk, Faeezah Patel, et al.. (2023). Safety surveillance for PrEP in pregnant and breastfeeding women. SHILAP Revista de lepidopterología. 5. 1221101–1221101. 7 indexed citations

10.

Scott, Lesley, Nicki Tiffin, Andrew Boulle, et al.. (2023). Translating the consent form is the tip of the iceberg: using cognitive interviews to assess the barriers to informed consent in South African health facilities. Sexual and Reproductive Health Matters. 31(4). 2302553–2302553. 3 indexed citations

11.

LeFevre, Amnesty, Nicki Tiffin, Amy L. Slogrove, et al.. (2023). Preferences for onward health data use in the electronic age among maternity patients and providers in South Africa: a qualitative study. Sexual and Reproductive Health Matters. 31(4). 2274667–2274667. 1 indexed citations

12.

Sawry, Shobna, Nicole Wolter, Philile Mbatha, et al.. (2022). High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa. International Journal of Infectious Diseases. 125. 241–249. 7 indexed citations

13.

Scorgie, Fiona, Lee Fairlie, Florence Mathebula, et al.. (2022). Acceptability of Implants for HIV Treatment in Young Children: Perspectives of Health Care Providers in Johannesburg, South Africa. AIDS Patient Care and STDs. 36(10). 389–395. 2 indexed citations

14.

Martinson, Neil, Lee Fairlie, H. Simon Schaaf, et al.. (2021). Challenges in recruiting children to a multidrug-resistant TB prevention trial. The International Journal of Tuberculosis and Lung Disease. 25(10). 814–822. 1 indexed citations

15.

Rabie, Helena, Janice Lee, Lee Fairlie, et al.. (2020). Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir. Antimicrobial Agents and Chemotherapy. 64(5). 4 indexed citations

16.

Venter, François, Michelle Moorhouse, Simiso Sokhela, et al.. (2019). Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. New England Journal of Medicine. 381(9). 803–815. 442 indexed citations breakdown →

17.

Fairlie, Lee, et al.. (2018). HIV retesting in pregnant women in South Africa: Outcomes of a quality improvement project targeting health systems’ weaknesses. Southern African Journal of HIV Medicine. 19(1). 784–784. 4 indexed citations

18.

Seddon, James A., Anthony J. Garcia‐Prats, Muhammad Osman, et al.. (2018). Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP). Trials. 19(1). 693–693. 45 indexed citations

19.

Agwu, Allison L., Meredith G. Warshaw, Elizabeth J. McFarland, et al.. (2017). Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial. PLoS ONE. 12(6). e0178075–e0178075. 11 indexed citations

20.

Jao, Jennifer, Lee Fairlie, David C. Griffith, & Allison L. Agwu. (2016). The Challenge of and Opportunities for Transitioning and Maintaining a Continuum of Care Among Adolescents and Young Adults Living with HIV in Resource Limited Settings. Current Tropical Medicine Reports. 3(4). 149–157. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact